Burney CO Abb Vie Inc. Transaction History

Burney CO

$2.37 Billion
Q2 2024

A detailed history of Burney CO transactions in Abb Vie Inc. stock. As of the latest transaction made, Burney CO holds 58,348 shares of ABBV stock, worth $11.4 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares

58,348

Previous 60,025 2.79%

Holding current value

$11.4 Million

Previous $10.9 Million 8.44%

% of portfolio

0.42%

Previous 0.46%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	SELL	$154.79 - $180.76 $259,582 - $303,134	-1,677 Reduced 2.79%	58,348 $10 Million
Q1 2024 May 22, 2024	SELL	$159.82 - $182.1 $46,507 - $52,991	-291 Reduced 0.48%	60,025 $10.9 Million
Q4 2023 Feb 12, 2024	BUY	$137.6 - $154.97 $556,454 - $626,698	4,044 Added 7.19%	60,316 $9.35 Million
Q3 2023 Nov 08, 2023	BUY	$133.59 - $154.65 $32,328 - $37,425	242 Added 0.43%	56,272 $8.39 Million
Q2 2023 Aug 09, 2023	SELL	$132.51 - $164.9 $129,859 - $161,602	-980 Reduced 1.72%	56,030 $7.55 Million
Q1 2023 May 10, 2023	SELL	$144.61 - $166.54 $1.97 Million - $2.26 Million	-13,589 Reduced 19.25%	57,010 $9.09 Million
Q4 2022 Feb 06, 2023	SELL	$138.31 - $165.87 $266,799 - $319,963	-1,929 Reduced 2.66%	70,599 $11.4 Million
Q3 2022 Nov 15, 2022	BUY	$134.21 - $153.93 $58,515 - $67,113	436 Added 0.6%	72,528 $9.73 Million
Q2 2022 Aug 12, 2022	SELL	$137.62 - $174.96 $274,551 - $349,045	-1,995 Reduced 2.69%	72,092 $11 Million
Q1 2022 May 09, 2022	SELL	$131.98 - $163.75 $95,025 - $117,900	-720 Reduced 0.96%	74,087 $12 Million
Q4 2021 Feb 11, 2022	SELL	$107.43 - $135.93 $173,499 - $219,526	-1,615 Reduced 2.11%	74,807 $10.1 Million
Q3 2021 Nov 12, 2021	SELL	$106.4 - $120.78 $85,439 - $96,986	-803 Reduced 1.04%	76,422 $8.24 Million
Q2 2021 Aug 06, 2021	BUY	$105.21 - $117.21 $128,777 - $143,465	1,224 Added 1.61%	77,225 $8.7 Million
Q1 2021 May 13, 2021	BUY	$102.3 - $112.62 $506,078 - $557,131	4,947 Added 6.96%	76,001 $8.23 Million
Q4 2020 Feb 11, 2021	BUY	$80.49 - $108.67 $86,446 - $116,711	1,074 Added 1.53%	71,054 $7.61 Million
Q3 2020 Dec 14, 2020	SELL	$85.91 - $100.83 $445,443 - $522,803	-5,185 Reduced 6.9%	69,980 $6.13 Million
Q2 2020 Aug 13, 2020	BUY	$73.37 - $98.18 $317,838 - $425,315	4,332 Added 6.12%	75,165 $7.38 Million
Q1 2020 May 13, 2020	BUY	$64.5 - $97.79 $151,833 - $230,197	2,354 Added 3.44%	70,833 $5.4 Million
Q4 2019 Feb 14, 2020	BUY	$72.13 - $90.25 $183,859 - $230,047	2,549 Added 3.87%	68,479 $6.06 Million
Q3 2019 Nov 12, 2019	SELL	$62.98 - $75.72 $1.87 Million - $2.25 Million	-29,732 Reduced 31.08%	65,930 $4.99 Million
Q2 2019 Aug 12, 2019	SELL	$65.7 - $83.98 $625,069 - $798,985	-9,514 Reduced 9.05%	95,662 $6.96 Million
Q1 2019 May 13, 2019	SELL	$77.14 - $90.79 $79,917 - $94,058	-1,036 Reduced 0.98%	105,176 $8.48 Million
Q4 2018 Feb 12, 2019	BUY	$77.85 - $96.01 $108,211 - $133,453	1,390 Added 1.33%	106,212 $9.79 Million
Q3 2018 Nov 13, 2018	SELL	$88.91 - $98.84 $4.48 Million - $4.98 Million	-50,425 Reduced 32.48%	104,822 $9.91 Million
Q2 2018 Aug 13, 2018	BUY	$89.78 - $106.23 $539,577 - $638,442	6,010 Added 4.03%	155,247 $14.4 Million
Q1 2018 May 08, 2018	SELL	$92.01 - $123.21 $1.13 Million - $1.51 Million	-12,251 Reduced 7.59%	149,237 $14.1 Million
Q4 2017 Feb 13, 2018	BUY	$89.56 - $98.21 $883,867 - $969,234	9,869 Added 6.51%	161,488 $15.6 Million
Q3 2017 Nov 13, 2017	SELL	$69.85 - $89.22 $391,090 - $499,542	-5,599 Reduced 3.56%	151,619 $13.5 Million
Q3 2017 Nov 09, 2017	BUY	$69.85 - $89.22 $11 Million - $14 Million	157,218	157,218 $11.4 Million

Others Institutions Holding ABBV

# of Institutions

3,694

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $344B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Burney CO, based on Form 13F filings with the SEC.

News

Stay updated on Burney CO with notifications on news.

Account